Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Endo International PLC (NASDAQ:ENDP)

12.34
Delayed Data
As of Jan 20
 -0.56 / -4.34%
Today’s Change
12.26
Today|||52-Week Range
61.14
-25.08%
Year-to-Date
The 10 Worst Stocks During the Obama Administration
Jan 20 / MotleyFool.com - Paid Partner Content
Deja Vu for Drug Stocks as Trump Slams Drug Pricing Again
Jan 12 / Zacks.com - Paid Partner Content
The Worst Performing Stock of 2016
Jan 17 / MotleyFool.com - Paid Partner Content
The 10 Worst Stocks in the S&P 500 in 2016
Jan 08 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close12.90
Today’s open12.68
Day’s range12.26 - 12.71
Volume7,978,124
Average volume (3 months)5,688,749
Market cap$2.8B
Dividend yield--
Data as of 4:00pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)-55.88%
Earnings growth (this year)-1.41%
Earnings growth (next 5 years)+2.00%
Revenue growth (last year)+13.61%
P/E ratio4.2
Price/Sales3.69
Price/Book0.46

Competitors

 Today’s
change
Today’s
% change
PBHPrestige Brands Hold...0.000.00%
ICPTIntercept Pharmaceut...-4.53-3.95%
HZNPHorizon Pharma PLC-0.06-0.36%
RAREUltragenyx Pharmaceu...-1.16-1.66%
Data as of 4:02pm ET, 01/20/2017

Financials

Next reporting dateFebruary 28, 2017
EPS forecast (this quarter)$1.65
Annual revenue (last year)$3.3B
Annual profit (last year)-$1.5B
Net profit margin-9.18%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Paul V. Campanelli
Chief Operating Officer &
Executive Vice President
Terrance J. Coughlin
Corporate headquarters
Dublin, Dublin

Forecasts


Search for Jobs